Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
British Journal of Cancer|January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trialE Samalin, O Bouché, S Thézenas, et al.Global Change Biology|January 26, 2024
The Coastal Carbon Library and Atlas: Open source soil data and tools supporting blue carbon research and policyJames R Holmquist, David Klinges, Michael Lonneman, et al.Toxicology Letters|January 26, 2021
Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyesPatrick M McNutt, Kyle E M Kelly, Amber C Altvater, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.European Journal of Cancer (Oxford, England : 1990)|September 27, 2005
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)A Brédart, A Bottomley, J M Blazeby, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapyP Rougier, R Bugat, J Y Douillard, et al.Bioorganic & Medicinal Chemistry Letters|March 1, 2018
Bicyclo((aryl)methyl)benzamides as inhibitors of GlyT1Jeffrey G Varnes, Hui Xiong, Janet M Forst, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45V Bjelic-Radisic, F Cardoso, D Cameron, et al.European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)A Adenis, J Bennouna, P L Etienne, et al.Tumori|July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative GroupJ Wils, T Sahmoud, A Sobrero, et al.Pageof 15